Contact this trialFirst, we need to learn more about you.
Antimetabolite
Venetoclax + Chemotherapy for Acute Myeloid Leukemia
Recruiting3 awardsPhase 1 & 2
Houston, Texas
This trial is testing venetoclax with chemotherapy drugs to treat patients with acute myeloid leukemia (AML). Venetoclax blocks enzymes needed for cancer cell growth, while the chemotherapy drugs kill or stop the spread of cancer cells. Venetoclax is a selective Bcl-2 inhibitor used for treating lymphomas and leukemias, including AML, and has shown improved outcomes when combined with other treatments.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service